FDA authorized Tregzi for adults with acute leukemia, MDS, and other hematologic malignancies receiving closely matched donor ...
Orca-T integrates HSPCs for reconstitution, highly purified Tregs for GVHD suppression, and Tcons to accelerate immune recovery and preserve graft-versus-leukemia activity via a matched-donor, patient ...
June 30 (Reuters) - The U.S. Food and Drug Administration has approved Orca Bio's cell therapy for the treatment of certain ...
Merck & Co., Inc. (NYSE:MRK) is one of billionaire Cliff Asness’ top 10 healthcare stock picks. On June 25, Merck & Co., Inc.
Morning Overview on MSN
The FDA approved the first oral carbapenem, Utebzi, for stubborn urinary infections
Adults with complicated urinary tract infections, including kidney infections, now have an oral antibiotic option that ...
The FDA has approved an allogeneic regulatory T cell immunotherapy for use in matched-donor hematopoietic stem cell transplantation in patients with blood cancers, to improve survival for chronic ...
FDA approved veligrotug-vvze for TED regardless of activity or duration, using a 12-week course of five IV infusions administered every three weeks. Pivotal THRIVE/THRIVE-2 trials met primary and all ...
Nicotine pouches, which users insert under their lip to get a nicotine buzz, are the fastest-growing nicotine product in the U.S.
With the FDA approval for Tregzi, Orca Bio has become one of the very few U.S.-based commercial drugmaker that remains privately held. (Getty Images) Orca Bio has jumped into the commercial market ...
A sunscreen ingredient that's been available in Europe, Japan and South Korea for years has finally been approved by the FDA for sale in the U.S.
MedPage Today on MSN
NEJM Retracts Pivotal Trial of FDA-Approved Drug
Move follows actions "inconsistent with proper research conduct," journal says ...
Texas Agriculture Commissioner Sid Miller calls on the FDA to approve medicated livestock feed amid a New World screwworm outbreak.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results